Digital nucleic acid detection based on microfluidics technology can quantify the initial
amount of nucleic acid in the sample with low equipment requirements and simple …

New point-of-care tests (POCTs), which are especially useful in low-resource settings, are
needed to expand screening capacity for diseases that cause significant mortality …

Circular RNA (circRNA) and microRNA (miRNA) are both non-coding RNAs (ncRNAs) that
serve as biomarkers for cancer diagnosis and prognosis. Quantitative detection of these …

Addressing the global disparity in cancer care necessitates the development of rapid and
affordable nucleic acid (NA) testing technologies. This need is particularly critical for cervical …

Infectious diseases continue to present significant challenges globally, with high mortality
rates and escalating healthcare costs. The Clustered Regularly Interspaced Short …

Rapid and precise nucleic acid testing at the point-of-care (POC) is essential for effective
screening and management of infectious diseases. Current polymerase-based molecular …

The emergence of CRISPR/Cas systems has revolutionized the field of molecular
diagnostics with their high specificity and sensitivity. This review provides a comprehensive …

The development of ultrasensitive biomarker analysis strategies is of great significance in
early disease diagnosis and human health. Superior to the conventional homogenous bulk …

The development of novel detection technology for meat species authenticity is imperative.
Here, we developed a machine learning-supported, dual-channel biosensor-in-microdroplet …

Highly sensitive and rapid environmental surveillance is crucial due to the significant role of
various environmental media in transmitting multiple viruses. Specifically, when examining …